| Page 1339 | Kisaco Research
 

Jan ter Meulen

CSO
Obsidian Therapeutics

Jan ter Meulen

CSO
Obsidian Therapeutics

Jan ter Meulen

CSO
Obsidian Therapeutics
 

Guanglin Yu

Senior Expert Science & Technology
Novartis

Guanglin Yu

Senior Expert Science & Technology
Novartis

Guanglin Yu

Senior Expert Science & Technology
Novartis
 

Paul Rennert

Acting CEO, President, CSO
Aleta Biotherapeutics

Paul Rennert

Acting CEO, President, CSO
Aleta Biotherapeutics

Paul Rennert

Acting CEO, President, CSO
Aleta Biotherapeutics
 

Laura Johnson

Chief Scientific Officer
Verismo Therapeutics

Laura Johnson

Chief Scientific Officer
Verismo Therapeutics

Laura Johnson

Chief Scientific Officer
Verismo Therapeutics
 

Francesco Marincola

Global Head of R&D
Kite Pharma

Francesco Marincola

Global Head of R&D
Kite Pharma

Francesco Marincola

Global Head of R&D
Kite Pharma
 

Christopher Pastorello

Director, Head of GMP Operations
Century

Christopher Pastorello

Director, Head of GMP Operations
Century

Christopher Pastorello

Director, Head of GMP Operations
Century
 

Peter Bross

Chief, Oncology Branch, Office of Tissues and Advanced Therapeutics, Center for Biologics Evaluation and Research
FDA

Peter Bross

Chief, Oncology Branch, Office of Tissues and Advanced Therapeutics, Center for Biologics Evaluation and Research
FDA

Peter Bross

Chief, Oncology Branch, Office of Tissues and Advanced Therapeutics, Center for Biologics Evaluation and Research
FDA
 

Michael Leek

Executive Chairman
TC Biopharm

Michael Leek

Executive Chairman
TC Biopharm

Michael Leek

Executive Chairman
TC Biopharm
 

Stefanie Bailey

Research Fellow
Massachusetts General Hospital and Harvard Medical School

Stefanie Bailey

Research Fellow
Massachusetts General Hospital and Harvard Medical School

Stefanie Bailey

Research Fellow
Massachusetts General Hospital and Harvard Medical School
 

Christian Hinrichs

Chief of the Section of Cancer Immunotherapy
Rutgers Cancer Institute of New Jersey

Christian Hinrichs

Chief of the Section of Cancer Immunotherapy
Rutgers Cancer Institute of New Jersey

Christian Hinrichs

Chief of the Section of Cancer Immunotherapy
Rutgers Cancer Institute of New Jersey